These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 19223737)

  • 1. [Treatment results of chemotherapy with S-1 for head and neck cancer].
    Shirasaki T; Maruya S; Namba A; Matsubara A; Shinkawa H
    Gan To Kagaku Ryoho; 2009 Feb; 36(2):237-40. PubMed ID: 19223737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of chemotherapy in head and neck cancer patients with residual or recurrent tumors after initial treatment].
    Katsuno M; Watanabe N; Sugio Y; Tachibana S; Tani Y; Sato N; Zusho H
    Gan To Kagaku Ryoho; 2010 Nov; 37(11):2109-13. PubMed ID: 21084809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outpatient chemotherapy with S-1 for recurrent head and neck cancer.
    Yamashita T; Shinden S; Watabe T; Shiotani A
    Anticancer Res; 2009 Feb; 29(2):577-81. PubMed ID: 19331206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outpatient oral chemotherapy with S-1 for unresectable or distant metastatic head and neck cancer.
    Maeda M; Yamashita T; Matsunobu T; Araki K; Tomifuji M; Shiotani A
    Anticancer Res; 2013 Aug; 33(8):3285-9. PubMed ID: 23898093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S-1 monotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck after progression on platinum-based chemotherapy.
    Yokota T; Onozawa Y; Boku N; Hamauchi S; Tsushima T; Taniguchi H; Todaka A; Machida N; Yamazaki K; Fukutomi A; Yasui H
    Jpn J Clin Oncol; 2011 Dec; 41(12):1351-7. PubMed ID: 21980053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Successful treatment results of S-1 administration in 2 patients, one with a remnant tumor of the larynx and metastatic tumors to the lung, and another with a metastatic tumor in the neck from the hypopharynx].
    Abo H; Tsukuda M; Matsuda H; Horiuchi C; Taguchi T; Watanabe M; Niho T
    Gan To Kagaku Ryoho; 2009 Oct; 36(10):1707-9. PubMed ID: 19838032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Adjuvant chemotherapy with S-1 for head and neck carcinoma].
    Terao K; Saito K; Mori K; Murata K
    Gan To Kagaku Ryoho; 2008 Mar; 35(3):425-9. PubMed ID: 18347390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II trial of S-1 plus low-dose cisplatin for unresectable and recurrent gastric cancer (JFMC27-9902 Step2).
    Nakata B; Tsuji A; Mitachi Y; Taenaka N; Kamano T; Oikawa K; Onoda N; Kambe M; Takahashi M; Shirasaka T; Morita S; Sakamoto J; Tanaka Y; Saji S; Hirakawa K
    Oncology; 2010; 79(5-6):337-42. PubMed ID: 21430401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction chemotherapy with S-1 plus cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck.
    Choi YJ; Chung JS; Shin HJ; Cho GJ; Wang SG; Lee BJ; Cho BM; Joo YD; Sohn CH
    J Laryngol Otol; 2008 Aug; 122(8):848-53. PubMed ID: 18047761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of S-1 chemotherapy in recurrent/metastatic head and neck cancer.
    Suzuki S; Ishikawa K
    J Infect Chemother; 2009 Oct; 15(5):335-9. PubMed ID: 19856075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combination chemotherapy of S-1/low-dose CDDP/lentinan for advanced gastric cancer].
    Hori T; Ikehara T; Takatsuka S; Fukuoka T; Tendo M; Tezuka K; Dan N; Nishino H; Hirakawa K
    Gan To Kagaku Ryoho; 2011 Feb; 38(2):293-5. PubMed ID: 21368498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical experience of chemotherapy with S-1/CDDP for highly-advanced gastric cancer].
    Uchima Y; Kosaka K; Kimura K; Okita Y; Sim JK; Aomatsu N; Hirata K; Lee WH; Lee T; Nishii T; Tei S; Takeuchi K
    Gan To Kagaku Ryoho; 2010 Jul; 37(7):1287-90. PubMed ID: 20647711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized scheduling feasibility study of S-1 for adjuvant chemotherapy in advanced head and neck cancer.
    Tsukuda M; Kida A; Fujii M; Kono N; Yoshihara T; Hasegawa Y; Sugita M;
    Br J Cancer; 2005 Oct; 93(8):884-9. PubMed ID: 16189518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of S-1 plus weekly CDDP for advanced gastric cancer].
    Kemmochi T; Egawa T; Mihara Y; Irino T; Ito Y; Nagashima A; Makino H; Yamamuro W
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2351-3. PubMed ID: 22202379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I/II trial of chemoradiotherapy with concurrent S-1 and cisplatin for clinical stage II/III esophageal carcinoma (JCOG 0604).
    Tahara M; Fuse N; Mizusawa J; Sato A; Nihei K; Kanato K; Kato K; Yamazaki K; Muro K; Takaishi H; Boku N; Ohtsu A
    Cancer Sci; 2015 Oct; 106(10):1414-20. PubMed ID: 26250827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I study of S-1 and nedaplatin for patients with recurrence of head and neck cancer.
    Kodaira T; Fuwa N; Tachibana H; Hidano S
    Anticancer Res; 2006; 26(3B):2265-8. PubMed ID: 16821599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [S-1 activity in non-small cell lung cancer in clinical practice].
    Inagaki M; Onuki T; Iguchi K; Ogata T; Hayashi Y; Saito K; Wakai Y; Takabe K; Shinohara Y; Suzuki K; Ohtani T; Horikoshi K
    Gan To Kagaku Ryoho; 2009 May; 36(5):763-7. PubMed ID: 19461174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility study of alternate-day S-1 as adjuvant chemotherapy for head and neck cancer.
    Moro Y; Kogashiwa Y; Sato D; Matsumoto Y; Nakamura T; Yamauchi K; Sakurai H; Kohno N
    Anticancer Res; 2015 Feb; 35(2):977-81. PubMed ID: 25667484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Two cases of giant metastatic cervical lymphnode from oral cancer responding to concurrent chemoradiotherapy with S-1].
    Kishimoto K; Yoshida S; Ono T; Yoshihama Y; Nishiyama A; Sasaki A
    Gan To Kagaku Ryoho; 2008 Oct; 35(10):1727-30. PubMed ID: 18931577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete Response Obtained with S-1 Plus CDDP Therapy in a Patient with Multiple Liver Metastases from Gastric Cancer.
    Nonoshita T; Otsuka S; Inagaki M; Iwagaki H
    Hiroshima J Med Sci; 2015 Dec; 64(4):65-9. PubMed ID: 26964156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.